PMID- 16221210 OWN - NLM STAT- MEDLINE DCOM- 20060120 LR - 20091119 IS - 0085-2538 (Print) IS - 0085-2538 (Linking) VI - 68 IP - 5 DP - 2005 Nov TI - Soluble fibronectin induces chemokine gene expression in renal tubular epithelial cells. PG - 2111-20 AB - BACKGROUND: Increasing proteinuria in kidney disease is associated with an increased risk of renal failure. Urinary proteins such as albumin induce inflammatory signaling and gene expression in tubular epithelial cells (TECs). Fibronectin is an extracellular matrix protein that can exist in soluble form and is excreted in the urine of patients with glomerular disease. METHODS: To explore the impact of soluble fibronectin on tubular epithelium, murine TECs were stimulated with soluble fibronectin and chemokine mRNA was determined by RNase protection assay. RESULTS: Fibronectin induced the expression of inflammatory chemokine genes, including monocyte chemoattractant protein-1 (MCP-1) (CCL2) and macrophage inflammatory protein-2 (MIP-2) within 2 hours in a dose-dependent manner. Phosphorylation of Src family tyrosine kinases was also increased in TECs following exposure to fibronectin. Src tyrosine kinases were involved in the fibronectin activation of MCP-1 since the Src inhibitors SU6656 and PP2 effectively reduced the induction of this chemokine. Fibronectin also induced the phosphorylation of extracellular signal-regulated protein kinase (ERK1/2) within minutes in TECs. The ERK kinase (MEK1/2) inhibitor U0126 inhibited the fibronectin induction of MCP-1 mRNA suggesting that ERK1/2 was also involved in this inflammatory pathway. Furthermore, fibronectin also induced phosphorylation of IkappaBalpha within 20 minutes in TECs. The nuclear factor-kappaB (NF-kappaB) inhibitors N-acetyl-L-cysteine (NAC) and pyrrolidinecarbodithioic acid (PDTC) effectively blocked fibronectin induction of MCP-1 mRNA. CONCLUSION: Soluble fibronectin activates MCP-1 gene expression in TECs via Src tyrosine kinases, ERK1/2 and NF-kappaB. These data provide further support to the concept that proteinuria per se contributes to the tubulointerstitial injury observed in glomerular disease. FAU - Ren, Li AU - Ren L AD - Division of Nephrology, Department of Medicine, University of Calgary, Alberta, Canada. FAU - Blanchette, Jason B AU - Blanchette JB FAU - White, Lindsay R AU - White LR FAU - Clark, Sharon A AU - Clark SA FAU - Heffner, Daniel J AU - Heffner DJ FAU - Tibbles, Lee Anne AU - Tibbles LA FAU - Muruve, Daniel A AU - Muruve DA LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Kidney Int JT - Kidney international JID - 0323470 RN - 0 (Ccl2 protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CXCL2) RN - 0 (Chemokines) RN - 0 (Cxcl2 protein, mouse) RN - 0 (Fibronectins) RN - 0 (NF-kappa B) RN - EC 2.7.10.2 (src-Family Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 3) SB - IM MH - Animals MH - Cells, Cultured MH - Chemokine CCL2/genetics MH - Chemokine CXCL2 MH - Chemokines/*genetics MH - Epithelial Cells/cytology/*drug effects/immunology MH - Fibronectins/*pharmacology MH - Gene Expression/drug effects/immunology MH - Kidney Tubules/*cytology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mitogen-Activated Protein Kinase 1/metabolism MH - Mitogen-Activated Protein Kinase 3/metabolism MH - NF-kappa B/metabolism MH - Solubility MH - src-Family Kinases/metabolism EDAT- 2005/10/14 09:00 MHDA- 2006/01/21 09:00 CRDT- 2005/10/14 09:00 PHST- 2005/10/14 09:00 [pubmed] PHST- 2006/01/21 09:00 [medline] PHST- 2005/10/14 09:00 [entrez] AID - S0085-2538(15)51107-1 [pii] AID - 10.1111/j.1523-1755.2005.00667.x [doi] PST - ppublish SO - Kidney Int. 2005 Nov;68(5):2111-20. doi: 10.1111/j.1523-1755.2005.00667.x.